Lupin Ltd. | LUPIN | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Revenue
Revenue
167,182153,748151,630165,472167,150
Cost of revenue
Cost of revenue
-58,458-54,306-53,622-64,812-67,798
Gross Profit
Gross Profit
108,724
99,442
98,007
100,659
99,353
Sales, general & ad...
Sales, general and administrative
-79,902-75,894-72,338-78,270-81,413
Depreciation
Depreciation and amortization
-10,850-9,702-8,874-16,587-8,807
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
000-18,100776
Operating income
Operating income EBIT
17,972
13,846
16,795
-12,298
9,908
 
      
Profit before tax
Profit before tax
15,1347,53316,751-13,7267,165
Net Income
Net income
6,059
-2,694
12,165
-15,280
4,301
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
13.40
-5.95
26.87
-33.65
9.46